ArticleHealth science reports2026
Association of Triglyceride With Incident Cancer: An Analysis of the Whole-Body Cancer Screening Program in Japan.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: To examine the association of cancer development with various risk factors, we used data from participants of a whole-body cancer screening program at the Hamamatsu Medical Imaging Center in Japan. Methods: For associations between cancer development and various risk factors, the Cox proportional hazards model was used to estimate the hazard ratio (HR) and its confidence intervals (CI) for developing cancer. Results: Of the 1495 participants, 59 developed cancers. In multivariable analysis, a statistically significant association was found with triglycerides (HR 1.004; 95% CI: 1.001-1.008) and with the presence of hypertension history (HR 2.88; 95% CI: 1.49-5.53). Conclusion: The study suggests that the baseline triglyceride may be a sensitive biomarker for cancer risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.